Dr. Winnie Yip is a Professor of the Practice of Global Health Policy and Economics at the Harvard T.H. Chan School of Public Health. She serves as Faculty Director of the China Health Partnership and recently concluded her role as Acting Director at Harvard's Fairbank Center for Chinese Studies. Previously, she was a Professor at the University of Oxford and led the Global Health Policy Program. She holds a PhD in Economics from MIT and a BA from UC Berkeley. Her research focuses on systemic healthcare interventions, policy design, and aging populations' impact on health systems. She collaborates closely with governments and international agencies like the World Bank and WHO, advising on reforms in Asia. Her work emphasizes equitable access, health system efficiency, and innovative eldercare solutions. Dr. Yip’s academic leadership includes roles as past President of the International Health Economics Association and editorial positions at journals like Social Science & Medicine . Her grants include funding from NSF, Bill & Melinda Gates Foundation, and EU Commission. Key areas of study include telemedicine, long-term care financing, and healthcare delivery in low-income regions.
Catherine Anne Brown is a Professor at the Faculty of Law, University of Calgary with extensive international experience, having held visiting professorships at Stanford University (as a Fulbright Fellow), University of Toronto, UCLA, McGeorge School of Law, and Whittier Law School. Her expertise spans taxation, international trade law, and estate planning across multiple jurisdictions. Her research focuses on the critical intersection of tax and trade agreements, particularly how non-discrimination principles operate within services trade frameworks. Current work examines tax treaty mechanisms for addressing discriminatory practices in cross-border commerce, building on her 2017 monograph "Tax Discrimination and Trade in Services". She actively explores evolving regulatory challenges in digital services taxation and international compliance. Professor Brown's scholarship demonstrates consistent engagement with practical legal applications, bridging academic theory and professional practice through textbooks, treatises, and policy-oriented analyses. Her publications reveal progressive specialization in tax-trade interfaces while maintaining foundational contributions to estate planning education. Her distinguished career has been recognized through: Lifetime Achievement Award (Canadian Tax Foundation, 2017) Doug Sherbaniuk Award for Distinguished Writing (Canadian Tax Foundation, 2014) Award for Distinguished Service in Legal Scholarship (Law Society of Alberta/Canadian Bar Association, 2011) Widdifield Award for estate planning scholarship (2006, 2012) Induction into the International Academy of Estate and Trust Law (2012) As an educator, she directed the Business Clinical program until 2014, providing practical training in business law applications. She maintains active professional engagement through appointments to the NAFTA Chapter 19 roster (2018), STEP Canada's Public Policy Committee (2016), and the Canada Revenue Agency's Offshore Compliance Advisory Committee (2016), while serving on the Legal Education Society of Alberta's Board of Directors.
Colleen Carey is an Associate Professor at the Jeb E. Brooks School of Public Policy, Cornell University. Her research focuses on the industrial organization of healthcare systems, particularly federal regulation of health insurance markets like Medicare and Medicaid. She examines topics such as reinsurance mechanisms, risk adjustment policies, and the impact of physician-industry financial relationships on prescribing behaviors. Carey is a Faculty Research Fellow at the National Bureau of Economic Research and previously held roles including Robert Wood Johnson Scholar in Health Policy Research and Staff Economist at the Council of Economic Advisers. Education: Bachelor’s Degree: Yale University Ph.D. in Economics: Johns Hopkins University Research Interests: Federal health insurance market design (e.g., ACA marketplaces) Adverse selection mitigation strategies in subsidized insurance Pharmaceutical industry practices and physician prescribing Opioid abuse policy evaluation Social Security Disability Insurance health outcomes Recent Work Trends: Her 2020-2025 publications emphasize healthcare policy evaluation, including analyses of Medicare Advantage enrollment dynamics, racial disparities in disability programs, and the effects of prescription drug marketing on clinical decisions. She consistently bridges economic theory with applied policy analysis. Scientific Awards and Roles: Editorial Board Member, American Journal of Health Economics Robert Wood Johnson Health Policy Research Scholar (2018-2020) NBER Faculty Research Fellow (ongoing) Advising and Grants: Though no formal advisees are listed, her research often involves collaborations with institutions like the Council of Economic Advisers and NBER. She contributes to policy discussions through evidence-based insights. Labs and Teams: Collaborates extensively with NBER’s Health Economics Group and maintains affiliations with Princeton’s Center for Health and Wellbeing.
Amitabh Chandra is the Ethel Zimmerman Wiener Professor of Public Policy at Harvard Kennedy School (HKS) and the Henry and Allison McCance Family Professor of Business Administration at Harvard Business School (HBS). He holds dual roles as Director of Health Policy Research at HKS and chairs several initiatives, including the Pagliuca Harvard Life Lab and the joint MS/MBA program in life sciences. His research focuses on healthcare pricing, pharmaceutical innovation, racial disparities in care, and Alzheimer’s treatment economics. Dr. Chandra has advised the U.S. Congress, the Massachusetts government on healthcare reform, and serves on the Congressional Budget Office’s Health Advisors Panel. His affiliations include the Malcolm Wiener Center for Social Policy and the Mossavar-Rahmani Center for Business and Government at HKS. His research spans biopharmaceutical capital allocation, Medicare drug negotiation policies, and the economic implications of healthcare cost-sharing. Notable recent work addresses price regulation in healthcare, orphan drug exemptions, and the impact of the Inflation Reduction Act on pharmaceutical innovation. Key Awards: ASHE Medal (under 40), Kenneth Arrow Award, Eugene Garfield Award Committees: Blavatnik Fellows Board, Health Affairs Council on Spending Grants: NIH funding (NIA, NICHD), Robert Wood Johnson Foundation He explores how economic principles shape healthcare systems, focusing on aligning drug pricing with therapeutic value and improving equitable access to treatments. His work bridges academia and policy, influencing national dialogues on healthcare reform and innovation incentives.
Lawton Robert Burns is the James Joo-Jin Kim Professor and Professor of Healthcare Management at the Wharton School, University of Pennsylvania . He serves as Co-Director of the Roy and Diana Vagelos Program in Life Sciences and Management and Chairperson of the Health Care Systems Department since 2008. His career spans academic roles at the University of Chicago, University of Arizona, and University of Wisconsin. Education: PhD in Sociology, University of Chicago (1981) MBA in Health Administration, University of Chicago (1984) MA, University of Chicago (1976) BA, Haverford College (1973) Dr. Burns specializes in healthcare organization design , strategic change , and supply chain dynamics . His work examines hospital-physician relationships , integrated delivery systems , and market forces in healthcare. His recent publications analyze Pharmacy Benefit Managers (PBMs) , Group Purchasing Organizations (GPOs) , and strategic implementation failures. Notable awards include the Arthur Anderson Distinguished Visitor (2001), Edwin Crosby Memorial Fellowship (1992-93), and Udall Fellowship (1990-91). His research has been featured in Knowledge at Wharton , LDI News , and American Political Science Review . Dr. Burns co-authors works with experts like David Dranove and Stephen Shortell , focusing on clinical integration , retail supply chains , and global healthcare models (India, China).
Ryan K. McBain is a Senior Policy Researcher at the RAND Corporation and an Adjunct Professor of Policy Analysis at the RAND School of Public Policy. His work focuses on designing and evaluating health policies targeting vulnerable populations, including those affected by mental health conditions, HIV/AIDS, homelessness, and poverty. He employs methodologies such as econometric analysis, cost-effectiveness modeling, and qualitative research. Internationally, he collaborates with organizations like the World Bank, WHO, and Partners In Health in sub-Saharan Africa and Haiti. McBain holds a D.Sc. and M.Sc. in Global Health (Health Economics & Policy Analysis) from Harvard University and a B.A. in Psychology from Gordon College and Oxford University. His research emphasizes telehealth trends, mental health crisis systems (e.g., 988 hotline preparedness), and the intersection of housing and healthcare access. He advocates for evidence-based solutions to address systemic inequities in healthcare delivery and advocates caution in leveraging AI for mental health interventions. Education: D.Sc. and M.Sc. in Global Health from Harvard University; B.A. in Psychology from Gordon College and Oxford University. Key Research Themes: Mental Health Policy, HIV/AIDS Programs, Telehealth Expansion, Homelessness Solutions. McBain’s recent work includes analyzing psychiatric bed shortages, evaluating permanent supportive housing programs, and assessing the competency of AI models in mental health contexts. He emphasizes interdisciplinary collaboration to bridge gaps between research and policy implementation.
Lawton R. Burns is the James Joo-Jin Kim Professor of Health Care Management and Professor of Management at the Wharton School, University of Pennsylvania. He serves as Co-Director of the Roy and Diana Vagelos Program in Life Sciences and Management and Chairperson of the Health Care Systems Department since 2008. Dr. Burns holds a PhD in sociology and an MBA in health administration from the University of Chicago, along with a BA from Haverford College. PhD, University of Chicago (1981) MBA, University of Chicago (1984) MA, University of Chicago (1976) BA, Haverford College (1973) His research focuses on healthcare supply chains, organizational innovation, and strategic management in health systems. He has authored or co-authored 15+ books, including analyses of integrated healthcare, pharmaceutical and medical device sectors, and global health systems in India and China. Recent works examine evidence-based healthcare innovation and the role of GPOs/PBMs in drug pricing. Dr. Burns advises on healthcare policy, including Senate testimony on pharmacy benefit managers and antitrust implications of physician-hospital organizations. His teaching covers healthcare strategy, managed care, integrated delivery networks, and the U.S. healthcare ecosystem, with courses requiring competitive analysis of producer, purchaser, and provider organizations. Board of Institute of Medicine, Health Services Research Section (2003) Arthur Anderson Distinguished Visitor, University of Cambridge (2001) Teacher of the Year, Administrative Medicine Program (1999) Edwin Crosby Memorial Fellowship (1992-93) Udall Fellowship (1990-91) Invited Lecture Series, Catholic University of Rome (1997)
Laurie Graham is a Lecturer at the Yale School of Public Health (YSPH) and an Adjunct Professor at Boston University’s School of Public Health, where she also serves on the Advisory Board for the Health Policy and Management Department. Her expertise lies at the intersection of healthcare, business strategy, and technology. She holds a B.A. in Geography from George Washington University and an M.P.H. in Health Policy Management from YSPH (2012). Professionally, Graham has over 15 years of experience in healthcare consulting, strategic leadership, and policy reform. Her roles include Senior Director of Corporate Strategy at Optum (UnitedHealth Group), Vice President of Growth at Cotiviti, and advisory work at ARPA-H. Her work focuses on transforming healthcare systems through value-based payment models, payer-provider partnerships, and cross-sector collaboration. She teaches courses like Leading Health Care Transformation at YSPH, emphasizing real-world application of strategic insights. Her research interests center on healthcare system innovation, equitable access, and leveraging technology to optimize public health outcomes. Despite no listed publications, her professional contributions highlight a focus on practical solutions for systemic challenges in healthcare delivery and policy.
John Z. Ayanian serves as the Alice Hamilton Distinguished University Professor of Medicine and Healthcare Policy at the University of Michigan, holding joint appointments as Professor of Internal Medicine in the Medical School, Professor of Health Management and Policy in the School of Public Health, and Professor of Public Policy in the Gerald R Ford School of Public Policy. As inaugural Director of the Institute for Healthcare Policy and Innovation (IHPI), he leads a consortium of 700 faculty members across 15 schools and maintains clinical practice as a general internist at Michigan Medicine. His academic foundation includes a Bachelor of Arts in history and political science from Duke University (1982), medical degree from Harvard Medical School (1987), and master's in public policy from Harvard Kennedy School (1987), followed by residency and fellowship at Brigham and Women’s Hospital and post-doctoral training in health services research at Harvard School of Public Health. Dr. Ayanian's research program investigates health equity, access to care, and quality of care with particular attention to social determinants including race/ethnicity, gender, socioeconomic status, and insurance coverage. His work critically examines Medicaid expansion impacts, Medicare Advantage disparities, and policy responses to health inequities, often utilizing large-scale claims databases and cross-institutional collaborations. Current projects include the federally-authorized evaluation of Michigan's Medicaid expansion program serving over 700,000 adults. Analysis of his 15 most recent publications (2025) reveals three dominant research thrusts: (1) Medicare Advantage vs Traditional Medicare comparisons across diverse clinical conditions, (2) Medicaid policy evaluation including unwinding impacts and expansion effects, and (3) innovative measurement of health equity through new indices and AI applications. His work consistently emphasizes methodological rigor in health services research while maintaining strong policy relevance. His scientific honors include: Election to the National Academy of Medicine Master status in the American College of Physicians John Eisenberg National Award for Career Achievement in Research Distinguished Investigator Award from AcademyHealth Election to Alpha Omega Alpha and Association of American Physicians Dr. Ayanian leads the federally-funded Healthy Michigan Plan evaluation team of 15 faculty members and serves as founding Editor-in-Chief of JAMA Health Forum, previously holding editorial positions at the New England Journal of Medicine. His research receives substantial federal support focused on health policy evaluation, with particular emphasis on vulnerable populations. He actively mentors students and junior faculty across multiple disciplines. As Director of IHPI, he fosters interdisciplinary collaboration across 15 schools at the University of Michigan. His leadership extends to center memberships in AI and Digital Health Innovation, Caswell Diabetes Institute, and Center for Global Health Equity, where he promotes data-driven solutions to health disparities through cross-campus partnerships and innovative research methodologies.
Dr Philip Haywood is an Associate Professor of Practice in Health Systems and Financing at the Leeder Centre for Health Policy, Economics and Data, part of the Sydney School of Public Health and the Faculty of Medicine and Health at the University of Sydney. His career spans academia, clinical practice in emergency medicine, and policy development. He has advised governments globally on health system resilience, particularly during the pandemic, and focuses on funding reforms, equity, and virtual care. Research interests include health system resilience, funding policy, equity, and integrated care. He leads the Centre for Research Excellence on Value-Based Payments in Cancer Care and contributes to cancer patient population projections. Currently supervising one PhD student, David GOLDSBURY, his work emphasizes applied health economics and policy. Publications span health economics, policy, and system resilience, with recent focus on pandemic responses, healthcare costs, and equity. His research has informed global health policies and is disseminated through platforms like the OECD and ICCONIC (International Comparisons). Labs/teams include the Leeder Centre, where he collaborates on projects like the Victorian Healthy Homes Program and resilience testing frameworks. No scientific awards are explicitly listed, but his contributions to policy and research are widely recognized.
Jeffrey D Marr is an Assistant Professor of Health Services, Policy, and Practice at Brown University’s School of Public Health. His research focuses on health care markets using quasi-experimental methods and administrative data, with current work emphasizing Medicare, private insurance, and AI applications in healthcare decision-making. Marr holds a PhD in Health Economics and Policy from Johns Hopkins University (2025) and a BA in Economics from Colgate University (2018). Key Affiliations: Brown University School of Public Health Research Themes: Algorithmic healthcare decision-making, Medicare Advantage networks, insurer market power, and post-acute care economics His research demonstrates how predictive algorithms reduce skilled nursing facility stays without compromising health outcomes, and how Medicare Advantage expansion impacts hospital pricing and provider networks. Marr’s work has been published in prestigious journals like Health Affairs , Health Services Research , and Journal of the American Geriatrics Society . His studies on Medicaid managed care reveal hospital pricing disparities linked to insurer bargaining power, while analyses of Medicare Advantage enrollment trends highlight shifts in supplemental insurance usage among elderly patients. Marr’s research also addresses critical issues like dialysis facility choice constraints and home-based care utilization differences between Medicare programs.
Kenneth A. Reinert is Professor of Public Policy at the Schar School of Policy and Government, George Mason University. He previously served as Director of the Global Commerce and Policy Program from 2007 to 2010 and again from 2013 to 2022, demonstrating sustained leadership in global economic policy education. His educational background includes a Ph.D. in Economics from the University of Maryland. Prior academic and professional roles include Associate Professor of Economics at Kalamazoo College and Senior International Economist at the U.S. International Trade Commission. Reinert's research centers on international economics, trade policy, economic development, globalization, and the universal provision of basic goods . His work bridges theoretical and applied economics, with a strong emphasis on policy relevance and human development. He explores how trade and economic integration affect inequality, sustainability, and access to essential services in developing nations. His recent publications reveal a thematic evolution from technical trade analysis toward broader critiques of economic nationalism and visions for equitable global development. Books like No Small Hope and The Lure of Economic Nationalism reflect a growing focus on ethical dimensions of globalization and inclusive economic frameworks. Scientific Awards: School of Public Policy Distinguished Teaching Award (2003) Reinert has advised major international institutions through consulting roles with the World Trade Organization, World Bank, OECD Development Centre, and U.S. Department of Commerce , indicating sustained engagement with global policy formulation. While no formal grants are listed, these affiliations imply participation in funded policy research initiatives. He has mentored students and early-career scholars, though specific advisees are not named in the provided texts. He currently serves as editor of Cambridge Elements in International Economics and has led major editorial projects, including the Princeton Encyclopedia of the World Economy and the Handbook of Globalisation and Development , positioning him as a key contributor to academic discourse in global economic policy.
Kate Ho is the John L. Weinberg Professor of Economics and Business Policy at Princeton University, where she also co-directed the Center for Health and Wellbeing (2018–2024). Her research focuses on the industrial organization of healthcare markets, with expertise in pharmaceutical policies, health insurance design, and provider-insurer interactions. She holds affiliations with the National Bureau of Economic Research (NBER) and the Center for Economic Policy Research (CEPR). Education includes a Ph.D. in Business Economics from Harvard University (2005) and degrees in Mathematics from Cambridge University (1993). Prior to academia, she served as Chief of Staff to the U.K. Minister of State for Health (1993–1997). Research interests emphasize healthcare market structure, drug pricing, and insurance competition. Recent work addresses formulary design, copayment coupons, and ACO savings. Awards include the Frisch Medal (2020) and Arrow Award (2010). She has edited leading journals like Econometrica and the RAND Journal of Economics . Teaching spans graduate courses in industrial organization and health economics at Princeton. Over 30 Ph.D. students have been advised, with placements at universities, policy institutions, and corporations. Active in professional service, including roles at the Congressional Budget Office and editorial leadership in economics. Labs/Teams: Co-leads Princeton’s Health and Wellbeing initiatives. Collaborates with researchers on projects funded by grants like the Commonwealth Fund ($50,000, 2015).
Jonathan Cylus is an Honorary Assistant Professor at the London School of Hygiene and Tropical Medicine and Adjunct Associate Professor of Health Services, Policy, and Practice at Brown University's School of Public Health. He leads the London Hub of the European Observatory on Health Systems and Policies, based at LSE and LSHTM, and serves as a Senior Health Economist at the WHO Barcelona Office for Health Systems Financing. His research focuses on health financing policy, health system performance, and the role of social determinants in health. Education: BA in Economics from Johns Hopkins University, MSc and PhD from LSE. Key expertise includes Universal Health Coverage, Health System Efficiency, and Social Determinants of Health. His research outputs emphasize resilience of health systems during crises, cross-country analysis of healthcare price trends, and the socio-economic impacts of population ageing. Recent work addresses inflation's threat to NHS sustainability and evaluates pandemic preparedness metrics in Europe. He has advised institutions like the European Commission, OECD, and WHO on health financing reforms. Professional networks include affiliations with ISGlobal and leadership roles in global health initiatives. No specific grants or awards are listed in the provided texts.
Roslyn C. Murray is an Assistant Professor of Health Services, Policy and Practice at Brown University's School of Public Health. She is affiliated with the Center for Advancing Health Policy through Research. Her research focuses on healthcare prices, private insurance markets, and policies to improve affordability in the U.S. healthcare system. Education: Ph.D. in Health Services Organization and Policy (2024) - University of Michigan MPP (2020) - Georgetown University BA in Human Biology (2015) - Stanford University Research Interests: Health economics, healthcare pricing power, Medicare Advantage, state-level healthcare price regulation, and the impact of payment policies on affordability and access. Publications Trends: Her work evaluates state-level interventions like Oregon's hospital payment caps and examines Medicare Advantage payment systems. Recent studies highlight cost reductions for enrollees and hospitals, with minimal adverse effects on care access. She also analyzes benchmark inflation and overpayments in Medicare Advantage. Awards: AcademyHealth 2025 Outstanding Dissertation Award, Honorable Mention Teaching & Grants: Taught microeconomics at Georgetown. Her grants include studies on healthcare cost containment and value-based payment models. She is part of the Center for Advancing Health Policy through Research, collaborating on policy-relevant studies. Labs/Teams: Active in the Center for Advancing Health Policy through Research (CAHPR), focusing on translating research into actionable policy recommendations.
